As of 2026-09-21, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is -1.48 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.45 CAD, the upside of Algernon Pharmaceuticals Inc is -429.42%.
Based on its market price of 0.45 CAD and our intrinsic valuation, Algernon Pharmaceuticals Inc (AGN.CN) is overvalued by 429.42%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.48 - -1.48 | -1.48 | -429.42% |
| P/E | (0.01) - (0.01) | (0.01) | -102.7% |
| DDM - Stable | (7.31) - 12.12 | 2.40 | 433.7% |
| DDM - Multi | (6.59) - 8.57 | (59.10) | -13233.8% |
| Market Cap (mil) | 3.59 |
| Beta | -0.27 |
| Outstanding shares (mil) | 7.97 |
| Enterprise Value (mil) | 3.38 |
| Market risk premium | 5.10% |
| Cost of Equity | 4.26% |
| Cost of Debt | 5.00% |
| WACC | 3.97% |